Department of Internal Medicine, The Catholic University of Korea School of Medicine, Seoul, Korea.
Korean J Intern Med. 2011 Jun;26(2):123-31. doi: 10.3904/kjim.2011.26.2.123. Epub 2011 Jun 1.
The number of patients with end-stage renal disease (ESRD) is rising very rapidly as the number of elderly and patients with diabetes increases in Korea. ESRD Registry Committee of the Korean Society of Nephrology (KSN) collected dialysis therapy data in Korea through an online registry program on the KSN website. The status of renal replacement therapy in Korea at the end of 2009 was as follows. First, total number of patients with ESRD was 56,396 (hemodialysis [HD], 37,391; peritoneal dialysis [PD], 7,618; functioning kidney transplant [KT], 11,387). The prevalence of ESRD was 1,113.6 patients per million population (PMP). Proportion of patients undergoing renal replacement therapy was 66.3% with HD, 13.5% with PD, and 20.2% with KT. Second, a total of 8,906 (HD, 6,540; PD, 1,125; KT, 1,241; incidence rate of 175.9 PMP) patients developed ESRD in 2009. Third, the most common primary causes of ESRD were diabetic nephropathy (45.4%), hypertensive nephrosclerosis (18.3%), and chronic glomerulonephritis (11.1%). Fourth, mean urea reduction rate was 67.5% and 73.8% in male and female patients, respectively, undergoing HD. Mean Kt/V was 1.38 in male patients and 1.65 in female patients. Fifth, the overall 5-year survival rate of male patients undergoing dialysis was 65.4% and that of female patients was 67.4%.
韩国老年人口和糖尿病患者数量不断增加，导致终末期肾病（ESRD）患者数量迅速增加。韩国肾脏病学会（KSN）的 ESRD 登记委员会通过 KSN 网站上的在线登记程序收集韩国的透析治疗数据。2009 年底韩国肾脏替代治疗的现状如下：首先，ESRD 患者总数为 56396 人（血液透析 [HD]37391 人，腹膜透析 [PD]7618 人，功能肾移植 [KT]11387 人）。ESRD 的患病率为每百万人口 1113.6 人。接受肾脏替代治疗的患者比例为 HD 占 66.3%，PD 占 13.5%，KT 占 20.2%。其次，2009 年共有 8906 名（HD6540 人，PD1125 人，KT1241 人，发病率为 175.9 PMP）患者发展为 ESRD。第三，ESRD 的主要病因是糖尿病肾病（45.4%）、高血压性肾硬化症（18.3%）和慢性肾小球肾炎（11.1%）。第四，接受 HD 的男性和女性患者的平均尿素降低率分别为 67.5%和 73.8%。男性患者的平均 Kt/V 为 1.38，女性患者为 1.65。第五，接受透析治疗的男性患者的总体 5 年生存率为 65.4%，女性患者为 67.4%。
